MarketLens

Pricing Plans Sign Up Log in

Stock Analysis Pro

What is a Mini-Tender Offer, and Why is Pfizer Rejecting It

1 hour ago

SHARE THIS ON:

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

What is Pfizer's Braftovi and Why Does it Matter for Investors

1 months ago

What is GLDY and Why is it Disruptive

3 weeks ago

What is Resource Nationalism and Why is it Surging

3 weeks ago

What is FatPipe and Why is it Under the Radar

2 weeks ago

Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLC

Pfizer recommended shareholders reject Tutanota LLC's unsolicited mini-tender offer to buy up to 1 million shares at $32.00 cash. The offer is conditional on Pfizer's closing stock price exceeding $32...

PFE

Stock News•1 week ago

Ruger Sets the Record Straight on Competitor Beretta's Attempt to Seize Control of Ruger

Ruger received notice on February 24, 2026, that competitor Beretta intends to nominate four candidates for the 2026 Annual Meeting of Stockholders' Board of Directors, prompting a review by Ruger.

RGR

Stock News•2 weeks ago

Can Pfizer Reignite Growth Amid COVID Declines and Patent Expirations?

Pfizer faces growth challenges from declining COVID sales, patent expirations, and IRA pressures. The company is focusing on cost reductions, new product launches, and pipeline rebuilding efforts to r...

PFE

Stock News•3 weeks ago

Faber Report: Victory Capital launches counterbid for Janus Henderson, taking on Trian deal

Victory Capital launched a counterbid for Janus Henderson, directly challenging the existing acquisition agreement with Trian Fund Management. This move introduces competitive tension into the potenti...

JHG